Factor IX concentrates unlike factor VIII concentrates have not to dat
e been associated with the transmission of hepatitis A virus (HAV), A
retrospective study by reverse transcriptase polymerase chain reaction
on a batch of factor IX concentrate used to treat two haemophilia B p
atients who developed jaundice and IgM anti-HAV antibodies within 50 d
ays of factor IX administration in 1985 revealed the presence of HAV R
NA, These findings indicate that factor IX concentrates can transmit H
AV and that appropriate viral inactivation steps to inactivate nonenve
loped viruses as well as enveloped viruses are necessary to ensure the
safety of factor IX concentrates.